The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas
Open accessAbstract
SUMMARY B cells foster squamous cell carcinogenesis (SCC) through deposition of immunoglobulin-containing immune complexes in premalignant tissue and Fcγreceptor-dependent activation of myeloid cells. Since human SCCs of the vulva and head and neck exhibited hallmarks of B cell infiltration, we examined B cell-deficient mice and found reduced ability to support SCC growth. Although ineffective as a single agent, treatment of mice bearing pre-existing SCCs with B cell-depleting αCD20 monoclonal antibodies improved response to platinum- and taxol-based chemotherapy. Improved chemo-responsiveness was dependent on altered chemokine expression by macrophages that fostered tumor infiltration of activated CD8+ T cells via CCR5-dependent mechanisms. These data reveal that B cells, and the downstream myeloid-based pathways they regulate, represent tractable targets for anti-cancer therapy in select tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B., Goodman, M. T., Sibug-Saber, M., Cozen, W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.4596 · Cited by 3,638
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,612
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
Self-citationMMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Self-citationSmall, E. J., Schellhammer, P. F., Higano, C. S., Redfern, C. H., Nemunaitis, J. J., Valone, F. H., Verjee, S. S., Jones, L. A., & Hershberg, R. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5252 · Cited by 1,108
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946 · cited 1×
“…of multistage epithelial carcinogenesis where HPV16 early region genes are expressed under control of a K14 promoter, i.e., K14-HPV16 mice (Arbeit et al., 1994; Coussens et al., 1996, 1999,2000; Daniel et al., 2003; de Visser et al., 2004, 2005; Rhee et al., 2004; van Kempen et al., 2002).”
Self-citationDe novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
de Visser, K. E., Korets, L. V., & Coussens, L. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.014 · Cited by 715
Self-citationOlkhanud, P. B., Damdinsuren, B., Bodogai, M., Gress, R. E., Sen, R., Wejksza, K., Malchinkhuu, E., Wersto, R. P., & Biragyn, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4316 · Cited by 684
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Ammirante, M., Luo, J.-L., Grivennikov, S., Nedospasov, S., & Karin, M. (2010) · Nature · doi:10.1038/nature08782 · Cited by 639
FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
Andreu, P., Johansson, M., Affara, N. I., Pucci, F., Tan, T., Junankar, S., Korets, L., Lam, J., Tawfik, D., DeNardo, D. G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.019 · Cited by 590
Self-citationBraselmann, S., Taylor, V., Zhao, H., Wang, S., Sylvain, C., Baluom, M., Qu, K., Herlaar, E., Lau, A., Young, C., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.109058 · Cited by 508
Leukocyte composition of human breast cancer
Ruffell, B., Au, A., Rugo, H. S., Esserman, L. J., Hwang, E. S., & Coussens, L. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104303108 · Cited by 479
Self-citationB cells inhibit induction of T cell-dependent tumor immunity
Qin, Z., Richter, G., Schüler, T., Ibe, S., Cao, X., & Blankenstein, T. (1998) · Nature Medicine · doi:10.1038/nm0598-627 · Cited by 419
Humoral immunity, inflammation and cancer
Tan, T.-T., & Coussens, L. M. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.01.001 · Cited by 417
Self-citationCD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
Nelson, B. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001323 · Cited by 416
Innate Response Activator B Cells Protect Against Microbial Sepsis
Rauch, P. J., Chudnovskiy, A., Robbins, C. S., Weber, G. F., Etzrodt, M., Hilgendorf, I., Tiglao, E., Figueiredo, J.-L., Iwamoto, Y., Theurl, I., et al. (2012) · Science · doi:10.1126/science.1215173 · Cited by 409
Ginos, M. A., Page, G. P., Michalowicz, B. S., Patel, K. J., Volker, S. E., Pambuccian, S. E., Ondrey, F. G., Adams, G. L., & Gaffney, P. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2144 · Cited by 407
Beyond Cervical Cancer: Burden of Other HPV-Related Cancers Among Men and Women
Chaturvedi, A. K. (2010) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2010.01.016 · Cited by 361
Inhibitory Effects of B Cells on Antitumor Immunity
Inoue, S., Leitner, W. W., Golding, B., & Scott, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3766 · Cited by 337
B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis
Schioppa, T., Moore, R., Thompson, R. G., Rosser, E. C., Kulbe, H., Nedospasov, S., Mauri, C., Coussens, L. M., & Balkwill, F. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100994108 · Cited by 328
Self-citationProgressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice
Arbeit, J. M., Münger, K., Howley, P. M., & Hanahan, D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4358-4368.1994 · Cited by 305
Hong, M., Puaux, A.-L., Huang, C., Loumagne, L., Tow, C., Mackay, C., Kato, M., Prévost-Blondel, A., Avril, M.-F., Nardin, A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1466 · Cited by 246
Shah, S., Divekar, A. A., Hilchey, S. P., Cho, H.-M., Newman, C. L., Shin, S.-U., Nechustan, H., Challita-Eid, P. M., Segal, B. M., Yi, K. H., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21177 · Cited by 227
Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice.
Coussens, L. M., Hanahan, D., & Arbeit, J. M. (1996) · Europe PMC (PubMed Central) · Cited by 206
Self-citationRegulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice
Horikawa, M., Minard-Colin, V., Matsushita, T., & Tedder, T. F. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59266 · Cited by 191
Macrophage polarization to a unique phenotype driven by B cells
Wong, S., Puaux, A., Chittezhath, M., Shalova, I., Kajiji, T. S., Wang, X., Abastado, J., Lam, K., & Biswas, S. K. (2010) · European Journal of Immunology · doi:10.1002/eji.200940288 · Cited by 184
Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells
Daniel, D., Meyer-Morse, N., Bergsland, E. K., Dehne, K., Coussens, L. M., & Hanahan, D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021047 · Cited by 180
Self-citationMoseman, E. A., Iannacone, M., Bosurgi, L., Tonti, E., Chevrier, N., Tumanov, A. V., Fu, Y., Hacohen, N., & von Andrian, U. H. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.013 · Cited by 177
Bahjat, F. R., Pine, P. R., Reitsma, A., Cassafer, G., Baluom, M., Grillo, S., Chang, B., Zhao, F. F., Payan, D. G., Grossbard, E. B., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23428 · Cited by 171
Tarella, C., Passera, R., Magni, M., Benedetti, F., Rossi, A., Gueli, A., Patti, C., Parvis, G., Ciceri, F., Gallamini, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9777 · Cited by 168
Huang, H., Benoist, C., & Mathis, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001074107 · Cited by 159
Albers, A. E., Abe, K., Hunt, J. L., Wang, J., López‐Albaitero, A., Schaefer, C., Gooding, W. E., Whiteside, T. L., Ferrone, S., DeLeo, A. B., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0772 · Cited by 155
Maximal T Cell–Mediated Antitumor Responses Rely upon CCR5 Expression in Both CD4+ and CD8+ T Cells
González-Martín, A., Gómez, L., Lustgarten, J., Mira, E., & Mañes, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1687 · Cited by 142
Barberá‐Guillem, E., Nelson, M. B., Barr, B. L., Nyhus, J. K., May, K. F., Feng, L., & Sampsel, J. W. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/pl00006672 · Cited by 138
Tadmor, T., Zhang, Y., Cho, H.-M., Podack, E. R., & Rosenblatt, J. D. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-0972-z · Cited by 135
Wansom, D., Light, E., Worden, F., Prince, M. E., Urba, S. G., Chepeha, D. B., Cordell, K. G., Eisbruch, A., Taylor, J. M. G., D’Silva, N. J., et al. (2010) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archoto.2010.211 · Cited by 117
Chapoval, A. I., Fuller, J. A., Kremlev, S. G., Kamdar, S. J., & Evans, R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6977 · Cited by 96
Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model
Ochoa‐Callejero, L., Pérez‐Martínez, L., Rubio-Mediavilla, S., Oteo, J. A., Martínez, A., & Blanco, J. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053992 · Cited by 93
Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment
van Kempen, L. C. L. T., Rhee, J.-S., Dehne, K., Lee, J., Coussens, L. M., Edwards, D. R., & Coussens, L. M. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700914.x · Cited by 88
Self-citationClinical status and optimal use of rituximab for B-cell lymphomas.
McLaughlin, P. J., White, C. A., Grillo-López, A. J., & Maloney, D. G. (1998) · PubMed · Cited by 84
B cells and their mediators as targets for therapy in solid tumors
Gunderson, A. J., & Coussens, L. M. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.005 · Cited by 82
Self-citationEnhanced Efficacy of Melanoma Vaccines in the Absence of B Lymphocytes
Perricone, M. A., Smith, K. A., Claussen, K. A., Plog, M. S., Hempel, D. M., Roberts, B., George, J. A. S., & Kaplan, J. M. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200407000-00003 · Cited by 81
Arbeit, J. M., Olson, D., & Hanahan, D. (1996) · PubMed · Cited by 76
Maurer, M., Rakočević, G., Leung, C. S. K., Quast, I., Lukačišin, M., Goebels, N., Münz, C., Wardemann, H., Dalakas, M. C., & Lünemann, J. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58743 · Cited by 74
CD4+ T Cell-Mediated Antigen-Specific Immunotherapy in a Mouse Model of Cervical Cancer
Daniel, D., Chiu, C. W., Giraudo, E., Inoue, M., Mizzen, L., Chu, N., & Hanahan, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3444 · Cited by 74
Therapeutic Targeting of Syk in Autoimmune Diabetes
Colonna, L., Catalano, G., Chew, C., D’Agati, V. D., Thomas, J. W., Wong, F. S., Schmitz, J., Masuda, E. S., Reizis, B., Tarakhovsky, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000983 · Cited by 68
TIMP-1 Alters Susceptibility to Carcinogenesis
Rhee, J.-S., Diaz, R. J., Korets, L. V., Hodgson, J., & Coussens, L. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2445 · Cited by 66
Self-citationSilverman, G. J. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22020 · Cited by 59
Early Neoplastic Progression Is Complement Independent
de Visser, K. E., Korets, L. V., & Coussens, L. M. (2004) · Neoplasia · doi:10.1593/neo.04250 · Cited by 47
Self-citationKobayashi, A., Darragh, T. M., HERNDIER, B. G., Anastos, K., Minkoff, H., Cohen, M. H., Young, M., Levine, A. M., Grant, L. A., Hyun, W. C., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64359-3 · Cited by 47
Cited by
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806
Macrophages as regulators of tumour immunity and immunotherapy
DeNardo, D. G., & Ruffell, B. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0127-6 · Cited by 2,528
Self-citationT cell exclusion, immune privilege, and the tumor microenvironment
Joyce, J. A., & Fearon, D. T. (2015) · Science · doi:10.1126/science.aaa6204 · Cited by 2,473
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nagarsheth, N., Wicha, M. S., & Zou, W. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.49 · Cited by 2,206
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Brand, A., Singer, K., Koehl, G. E., Kolitzus, M., Schoenhammer, G., Thiel, A., Matos, C., Bruss, C., Klobuch, S., Peter, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.011 · Cited by 2,039
Metadata
- Authors
- Affara, N. I., Ruffell, B., Medler, T. R., Gunderson, A. J., Johansson, M., Bornstein, S., Bergsland, E., Steinhoff, M., Li, Y., Gong, Q., Ma, Y., Wiesen, J. F., Wong, M. H., Kulesz-Martin, M., Irving, B., & Coussens, L. M.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 25
- Issue
- 6
- Pages
- 809-821
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2016967137
- Cited by
- 304
- References
- 52
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.